• Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

    Recruiting

    3 1 1 1
    Austria Belgium France Germany Greece Italy +3
  • A study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Italy The Netherlands Spain +1
  • A Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy

    Recruiting

    3 1
    Denmark France Germany Italy The Netherlands Spain
  • Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +2
  • A study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium France Germany Greece Italy The Netherlands +1
  • A Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria

    Recruiting

    3 1
    Czechia France Germany Italy The Netherlands Poland +1
  • Study of herbal medicine combination and bromazepam for anxiety and pain in patients having eye surgery with retrobulbar anesthesia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria
  • Testing trifluridine, tipiracil and nanoliposomal irinotecan combination for patients with bile duct or gallbladder cancer after previous treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

    Recruiting

    3 1 1
    Investigated Diseases:
    Germany
  • Study of lidocaine to reduce opioid use in patients with sickle cell disease experiencing severe pain crisis

    Recruiting

    3 1 1
    Investigated Diseases:
    France

powered by